نتائج البحث - "Caroline Robert"

1

961 Preliminary results of a phase 2 study of intratumoral administration of BO-112 with pembrolizumab in patients with advanced melanoma that have progressive disease on anti-PD-1-based therapy

المصدر: Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e402ca5ac12d03a7ed527395e7f52c31Test
https://doaj.org/article/cfa232992c194eb9b490f0ff34e0deecTest

2

Post-shingles granulomatous dermatosis related to anti-programmed cell death 1

المؤلفون: Vincent Ribrag, Jean-Marie Michot, Tony Ibrahim, Peggy Dartigues, David Ghez, Julien Lazarovici, Tarek Assi, Caroline Robert, Christine Mateus, Marie Terroir-Cassou-Mounat, Julien Rossignol, Alina Danu

المصدر: Immunotherapy. 11:591-598

مصطلحات موضوعية: 0301 basic medicine, Herpesvirus 3, Human, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, Immunology, Pembrolizumab, Antibodies, Monoclonal, Humanized, Herpes Zoster, Skin Diseases, 03 medical and health sciences, Antineoplastic Agents, Immunological, 0302 clinical medicine, Programmed cell death 1, Dermatomal, Humans, Immunology and Allergy, Medicine, Adverse effect, Neoplasm Staging, Skin, Granuloma, biology, business.industry, Remission Induction, Cancer, Middle Aged, medicine.disease, Hodgkin Disease, Magnetic Resonance Imaging, Dermatology, Stage IV Hodgkin Lymphoma, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, biology.protein, Female, Immunotherapy, Tomography, X-Ray Computed, business, Shingles

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::57337d95d1038366e184dcaf5976de42Test
https://doi.org/10.2217/imt-2018-0169Test

3

Inflammatory bowel disease and cancer response due to anti-CTLA-4: is it in the flora?

المؤلفون: Franck Carbonnel, Emilie Soularue, Christine Mateus, Caroline Robert, Patricia Lepage, Clélia Coutzac, Nathalie Chaput

المساهمون: Department of Gastroenterology, AP-HP Hôpital Bicêtre (Le Kremlin-Bicêtre), Université Paris Sud (Paris 11), Laboratoire d’Immunomonitoring en Oncologie (LIO), Analyse moléculaire, modélisation et imagerie de la maladie cancéreuse (AMMICa), Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris-Sud - Paris 11 (UP11)-Institut Gustave Roussy (IGR)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), US23 Institut de recherche intégrée en cancérologie, Institut National de la Santé et de la Recherche Médicale (INSERM), Faculté de pharmacie, Université catholique du Graben, Service de dermatologie, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), MICrobiologie de l'ALImentation au Service de la Santé (MICALIS), Institut National de la Recherche Agronomique (INRA)-AgroParisTech, Université Paris-Saclay

المصدر: Seminars in Immunopathology
Seminars in Immunopathology, Springer Verlag, 2017, 39 (3), pp.327-331. ⟨10.1007/s00281-016-0613-x⟩

مصطلحات موضوعية: 0301 basic medicine, [SDV]Life Sciences [q-bio], medicine.medical_treatment, Immunology, chemical and pharmacologic phenomena, Ipilimumab, Pembrolizumab, Gut flora, Inflammatory bowel disease, Immunomodulation, 03 medical and health sciences, 0302 clinical medicine, Cancer immunotherapy, Neoplasms, medicine, Humans, Immunology and Allergy, CTLA-4 Antigen, Molecular Targeted Therapy, Intestinal Mucosa, Enterocolitis, biology, business.industry, Antibodies, Monoclonal, Cancer, Colitis, Inflammatory Bowel Diseases, medicine.disease, biology.organism_classification, 3. Good health, Intestines, 030104 developmental biology, 030220 oncology & carcinogenesis, Immunotherapy, medicine.symptom, Nivolumab, business, medicine.drug